New SEC Form D filing
Insignis Therapeutics Inc., 2026-08-05
A new SEC Form D private-offering notice from North Haven, CT, a $8,500,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Insignis Therapeutics Inc. Verified via SEC Form D
Biotech developing an oral epinephrine tablet as an alternative to injectable treatments for anaphylaxis
Filed 2026-08-05Filed to raise $8,500,000First money in 2026-06-11Raised so far $5,999,714HQ (as filed) North Haven, CTSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Salvation Drinks Inc., 2026-08-13, $5M, Plainville, CT
- US KIDNEY RESEARCH Corp, 2026-08-06, $475K, Roseville, CA
- Skin Union Group Inc., 2026-08-12, $1M, West Cornwall, CT
- Integrated Biosciences, Inc., 2026-08-05, $100M, Redwood City, CA
- Convexity Scientific Inc., 2026-08-07, $13M, New Haven, CT
- Oncologic, Inc. / DE, 2026-08-05, $26.7M, Orlando, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.